Fallbericht
FIRST REPORT OF MSI-H SYNCHRONOUS HILAR CHOLANGIOCARCINOMA AND PANCREATIC ADENOCARCINOMA WITH DURABLE RESPONSE TO IMMUNOTHERAPY, CASE REPORT.
HPB · 2026 · 28 · S221-S222
DOI: 10.1016/j.hpb.2026.04.371 ↗Kurz gefasst
Fallbericht in der Zeitschrift HPB, 2026. Verfasst von A. Shaker und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shaker, A., Vasudevan, S., Thiyagarajan, S., Poruk, K., Majeed, U., & Stauffer, J. (2026). FIRST REPORT OF MSI-H SYNCHRONOUS HILAR CHOLANGIOCARCINOMA AND PANCREATIC ADENOCARCINOMA WITH DURABLE RESPONSE TO IMMUNOTHERAPY, CASE REPORT. HPB, 28, S221-S222. https://doi.org/10.1016/j.hpb.2026.04.371
Vancouver
Shaker A, Vasudevan S, Thiyagarajan S, Poruk K, Majeed U, Stauffer J. FIRST REPORT OF MSI-H SYNCHRONOUS HILAR CHOLANGIOCARCINOMA AND PANCREATIC ADENOCARCINOMA WITH DURABLE RESPONSE TO IMMUNOTHERAPY, CASE REPORT. HPB. 2026;28:S221-S222. doi:10.1016/j.hpb.2026.04.371
BibTeX
@article{Shaker2026,
author = {Shaker, A. and Vasudevan, S. and Thiyagarajan, S. and Poruk, K. and Majeed, U. and Stauffer, J.},
title = {FIRST REPORT OF MSI-H SYNCHRONOUS HILAR CHOLANGIOCARCINOMA AND PANCREATIC ADENOCARCINOMA WITH DURABLE RESPONSE TO IMMUNOTHERAPY, CASE REPORT},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S221--S222},
doi = {10.1016/j.hpb.2026.04.371}
}
EUVIMED